Obstructive sleep apnea (OSA) significantly impacts cardiovascular health, demonstrated by
observational investigations showing an independently increased risk of ischemic heart …

Background: Continuous positive airway pressure (CPAP) has been utilized to reduce blood
pressure in obstructive sleep apnea (OSA) patients, but few studies are available in terms of …

Obstructive sleep apnoea (OSA) is a common health concern caused by repeated episodes
of collapse of the upper airway during sleep. The events associated with OSA lead to brain …

Obstructive sleep apnea (OSA) is a highly prevalent and underdiagnosed medical condition,
which is associated with various cardiovascular and metabolic diseases. The current …

The prevalence of obstructive sleep apnea (OSA) is extremely high in patients with
cardiovascular disease (CVD), and previous studies have shown an association between …

Continuous positive airway pressure (CPAP) is the first-line treatment of obstructive sleep
apnea (OSA). Obstructive sleep apnea is a predictor of cardiovascular (CV) events. In this …

The sleep apnea cardiovascular endpoints (SAVE) study (Clinical Trials Registration
Number: NCT00738170) is an academic initiated and conducted, multinational, open …

Abstract The American Heart Association and the NIH report annual statistics related to heart
disease, stroke, and cardiovascular risk factors associated with cardiovascular disease …

The search for cardiovascular benefit from treating obstructive sleep apnoea with CPAP
therapy Page 1 ........................................................................................................ The search for …

Continuous positive airway pressure (CPAP) is the first-line treatment for obstructive sleep
apnea (OSA). Although CPAP improves symptoms (eg, daytime sleepiness), there is a lack …